China · Delayed Price · Currency is CNY Zhejiang Medicine Statistics
Total Valuation
SHA:600216 has a market cap or net worth of CNY 12.02 billion. The enterprise value is 9.37 billion.
| Market Cap | 12.02B |
| Enterprise Value | 9.37B |
Important Dates
The last earnings date was Wednesday, August 26, 2026.
| Earnings Date | Aug 26, 2026 |
| Ex-Dividend Date | Jul 9, 2026 |
Share Statistics
SHA:600216 has 947.91 million shares outstanding. The number of shares has decreased by -0.75% in one year.
| Current Share Class | 947.91M |
| Shares Outstanding | 947.91M |
| Shares Change (YoY) | -0.75% |
| Shares Change (QoQ) | +1.09% |
| Owned by Insiders (%) | 0.43% |
| Owned by Institutions (%) | 10.04% |
| Float | 568.32M |
Valuation Ratios
The trailing PE ratio is 15.10 and the forward PE ratio is 11.85.
| PE Ratio | 15.10 |
| Forward PE | 11.85 |
| PS Ratio | 1.34 |
| PB Ratio | 0.99 |
| P/TBV Ratio | 1.09 |
| P/FCF Ratio | 11.67 |
| P/OCF Ratio | 7.81 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.27, with an EV/FCF ratio of 9.10.
| EV / Earnings | 11.62 |
| EV / Sales | 1.05 |
| EV / EBITDA | 6.27 |
| EV / EBIT | 11.69 |
| EV / FCF | 9.10 |
Financial Position
The company has a current ratio of 4.10, with a Debt / Equity ratio of 0.08.
| Current Ratio | 4.10 |
| Quick Ratio | 2.96 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | 0.61 |
| Debt / FCF | 0.88 |
| Interest Coverage | 32.28 |
Financial Efficiency
Return on equity (ROE) is 5.54% and return on invested capital (ROIC) is 7.10%.
| Return on Equity (ROE) | 5.54% |
| Return on Assets (ROA) | 3.45% |
| Return on Invested Capital (ROIC) | 7.10% |
| Return on Capital Employed (ROCE) | 6.21% |
| Weighted Average Cost of Capital (WACC) | 5.74% |
| Revenue Per Employee | 1.65M |
| Profits Per Employee | 148,807 |
| Employee Count | 5,417 |
| Asset Turnover | 0.62 |
| Inventory Turnover | 2.88 |
Taxes
In the past 12 months, SHA:600216 has paid 161.33 million in taxes.
| Income Tax | 161.33M |
| Effective Tax Rate | 19.85% |
Stock Price Statistics
The stock price has decreased by -16.85% in the last 52 weeks. The beta is 0.33, so SHA:600216's price volatility has been lower than the market average.
| Beta (5Y) | 0.33 |
| 52-Week Price Change | -16.85% |
| 50-Day Moving Average | 12.50 |
| 200-Day Moving Average | 13.96 |
| Relative Strength Index (RSI) | 47.53 |
| Average Volume (20 Days) | 41,015,963 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:600216 had revenue of CNY 8.94 billion and earned 806.09 million in profits. Earnings per share was 0.84.
| Revenue | 8.94B |
| Gross Profit | 2.80B |
| Operating Income | 801.30M |
| Pretax Income | 812.56M |
| Net Income | 806.09M |
| EBITDA | 1.48B |
| EBIT | 801.30M |
| Earnings Per Share (EPS) | 0.84 |
Balance Sheet
The company has 4.00 billion in cash and 911.47 million in debt, with a net cash position of 3.09 billion or 3.26 per share.
| Cash & Cash Equivalents | 4.00B |
| Total Debt | 911.47M |
| Net Cash | 3.09B |
| Net Cash Per Share | 3.26 |
| Equity (Book Value) | 12.10B |
| Book Value Per Share | 12.06 |
| Working Capital | 6.05B |
Cash Flow
In the last 12 months, operating cash flow was 1.54 billion and capital expenditures -509.61 million, giving a free cash flow of 1.03 billion.
| Operating Cash Flow | 1.54B |
| Capital Expenditures | -509.61M |
| Depreciation & Amortization | 680.08M |
| Net Borrowing | 53.14M |
| Free Cash Flow | 1.03B |
| FCF Per Share | 1.09 |
Margins
Gross margin is 31.35%, with operating and profit margins of 8.96% and 9.01%.
| Gross Margin | 31.35% |
| Operating Margin | 8.96% |
| Pretax Margin | 9.09% |
| Profit Margin | 9.01% |
| EBITDA Margin | 16.56% |
| EBIT Margin | 8.96% |
| FCF Margin | 11.52% |
Dividends & Yields
This stock pays an annual dividend of 0.28, which amounts to a dividend yield of 2.20%.
| Dividend Per Share | 0.28 |
| Dividend Yield | 2.20% |
| Dividend Growth (YoY) | -24.32% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 46.66% |
| Buyback Yield | 0.75% |
| Shareholder Yield | 2.95% |
| Earnings Yield | 6.71% |
| FCF Yield | 8.57% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for SHA:600216 is 17.00, which is 34.07% higher than the current price. The consensus rating is "Buy".
| Price Target | 17.00 |
| Price Target Difference | 34.07% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | 3.22% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
The last stock split was on October 9, 2013. It was a forward split with a ratio of 1.8.
| Last Split Date | Oct 9, 2013 |
| Split Type | Forward |
| Split Ratio | 1.8 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |